Related content

Should low-dose mycophenolate mofetil be used to prolong the response after rituximab therapy in patients with immune thrombocytopenic purpura? A case report

By Bruserud Øyvind   Håvardstein Kathrine  

Hematology, Vol. 14, Iss. 4, 2009-08 ,pp. : 224-226

Maney Publishing

Access to resources Recommend Favorite

Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses

By Kumar S.   Diehn F.   Gertz M.   Tefferi A.  

Annals of Hematology, Vol. 81, Iss. 6, 2002-06 ,pp. : 312-319

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP)

By Alasfoor Kholood  

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 239-243

Springer Publishing Company

Access to resources Recommend Favorite

Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: Report of four cases

By Peque駉-Lu関ano Myrna   Villarreal-Mart韓ez Laura   Jaime-P閞ez Jos?Carlos   G髆ez-de-Le髇 Andr閟   Cant?Rodr韌uez Olga Graciela   Gonz醠ez-Llano Oscar   G髆ez-Almaguer David  

Hematology, Vol. 18, Iss. 4, 2013-07 ,pp. : 233-236

Maney Publishing

Access to resources Recommend Favorite

Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab

By Chemnitz Jens   Uener Jens   Hallek Michael   Scheid Christof  

Annals of Hematology, Vol. 89, Iss. 10, 2010-10 ,pp. : 1029-1033

Springer Publishing Company

Access to resources Recommend Favorite